Drug-makers could one day make products faster because of a $2.5 million National Science Foundation (NSF)-funded project now underway at the University of Maryland, Baltimore (UMB) and three other sites.
The cyber-infrastructure project goes to the heart of a current dilemma facing scientists trying to conduct efficient drug discovery and development from the massive data available on the human genome, says Alexander MacKerell, Grollman-Glick Professor of Pharmaceutical Sciences at the University of Maryland School of Pharmacy.
Scientists who look for new therapeutic drug opportunities from human gene and protein data have, in turn, created a “huge number of computational tools based on the mathematical models and parameters to biological molecules,” says MacKerell, who is director of the Computer-Aided Drug Design Center at the School of Pharmacy and principal investigator for the project. But, he says, such software tools are not one-size-fits-all. They are designed for different categories of molecules.
“Right now it is very tedious and time consuming to set up these mathematical models and parameters for the new molecules. Our cyber infrastructure will make this much faster. We are going to put the parameter engine in place to do the work for the scientist.”
Also funded for the cyber-infrastructure project are the Universities of Kentucky, Florida, and Illinois. Across the four universities, the project will also have applications in facilitating the design of electronics and the study of a wide range of material science and biological systems at the most basic level, in addition to drug design applications.
The project is aimed toward putting the parameter engine online. Researchers will go to the Internet, enter their drug molecule, and get the best model and the correct parameters for making their investigation more efficient. The proposed engine will provide an open architecture for obtaining and testing parameters under various conditions.
Ordinarily, once a drug company identifies a new drug candidate for the treatment of a particular medical problem, the next step is optimizing the drug candidate to improve its therapeutic potential. This is a huge task that involves testing hundreds of molecules, a task that can be facilitated using computational tools, says MacKerell. “We are trying to allow for computational tools to be rapidly applied to large numbers of molecules. We want to automate this process. To do so will allow computational scientists to work with biologists, thereby decreasing the time and cost required to develop new drug candidates.”
Also, the project will include annual workshops for education and outreach.
The basis for the Computer-Aided Drug Design Center is to ease the discovery of novel therapeutic agents that combines rational drug design methods with chemistry and structural biology. The computer-aided drug design approach allows researchers to use information available in 3-D structures of biological target molecules, which may be associated with human diseases, to identify chemicals that have a great potential for binding to those target molecules. Chemical compounds developed by such steps can often be developed into research tools and/or therapeutic agents. The NSF cyber-infrastructure project will help make this potential a reality.
Robert Latour, PhD, the McQueen-Quattlebaum Professor of Bioengineering at Clemson University, wrote a letter to the NSF supporting the project “because this is very important for a much broader spectrum of applications. It has enormous potential down the road to design things at the atomic level,” he said. Latour uses the same computational chemistry technology to simulate the interactions between biological molecules, such as proteins, and synthetic materials at the atomic level, aimed toward developing more accurate devices to detect biowarfare agents, more biocompatible implants for the human body, and other bionanotechnology applications.
Steve Berberich | Newswise Science News
Further reports about: > CHEMISTRY > Computational > Computer-Aided Drug Design Center > Cyber Chemistry > Design > Design Thinking > Drug Delivery > Drug-Making > Scientist > atomic level > biocompatible implants > biological molecules > biological system > bionanotechnology applications > computational chemistry technology > computational tools > cyber-infrastructure project > human genome > material science > therapeutic
Mitochondria control stem cell fate
27.10.2016 | Technische Universität München
How a fungus inhibits the immune system of plants
27.10.2016 | Julius-Maximilians-Universität Würzburg
Ultrafast lasers have introduced new possibilities in engraving ultrafine structures, and scientists are now also investigating how to use them to etch microstructures into thin glass. There are possible applications in analytics (lab on a chip) and especially in electronics and the consumer sector, where great interest has been shown.
This new method was born of a surprising phenomenon: irradiating glass in a particular way with an ultrafast laser has the effect of making the glass up to a...
Terahertz excitation of selected crystal vibrations leads to an effective magnetic field that drives coherent spin motion
Controlling functional properties by light is one of the grand goals in modern condensed matter physics and materials science. A new study now demonstrates how...
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
27.10.2016 | Life Sciences
27.10.2016 | Life Sciences
26.10.2016 | Power and Electrical Engineering